Boschman et. al.,"In vitro inhibition of ADP-induced patelet aggregation by O-(aminoalkyl) oxime ethers" Eur. J. Med. Chem.-Chem Therapeutica, Jul.-Aug. 1980, 15, No.4 pp.351-356 (1980). |
Chapman, J.D., "Measurement of Tumor Hypoxia by Invasive and Non-Invasive Procedures: A Review of Recent Clinical Studies", Radiother. Oncol., 20, pp. 13-19 (1991). |
Martin, G. V. et al., "Enhanced Binding of the Hypoxic Cell Marker [.sup.3H ]Fluoromisonidazole in Ischemic Myocardium", J. Nucl. Med., vol. 30, No. 2, 194-201 (1989). |
Hoffman, J.M. et al., "Binding of the Hypoxia Tracer [.sup.3H ]Misonidazole in Cerebral Ischemia". Stroke, 18:168-176 (1987). |
Koh, W.J. et al., "Hypoxia Imaging of Tumors Using [F-18] Fluoromisonidazole", J.Nucl.Med., 30,789 (No. 252) (1989). |
Biskupiak, J.E. et al., "Synthesis of an (Iodovinyl)misonidazole Derivative for Hypoxia Imagaing", J. Med. Chem., 34, pp. 2165-2168 (1991). |
Chapman, J.D., "The Detection and Measurement of Hypoxic Cells in Solid Tumors", Cancer, Vo. 54, No.11, pp. 2441-2449 (1984). |
Kedderis, G.L. et al., "The Metabolic Activation of Nitroheterocyclic Therapeutic Agents", Drug Metabolism Reviews, 19(1), pp. 33-62 (1988). |
Adams, G.E. et al., "Hypoxia-Mediated Nitro-Heterocyclic Drugs in The Radio-and Chemothrapy of Cancer", Biochemical Pharmacology, vol. 35, No. 1, pp. 71-76 (1986). |
Brown, D.M. et al., "Structure-Activity Reationships of 1-Substituted 2-Nitroimidazoles: Effect of Partition Coefficient and Side-chain Hydroxyl Groups on Radiosensitization In Vitro", Radiation Research, 90, pp. 98-108 (1982). |
Adams, G.E., et al., "Structure Activity Relationships in the Development of Hypoxic Cell Radiosensitizers. I. Sensitizatoin Efficiency", Int. J. Radiat. Biol., vol. 35, No. 2, pp. 133-150 (1979). |
Adams, G.E., et al., "Structure Activity Relationships in the Development of Hypoxic Cell Radiosensitizers. III. Effects of Basic Substituents in Nitromidazole Sidechains", Int. J. Radiat. Biol., vol. 38, No. 6, pp. 613-626 (1980). |
Jerabek, P.A., et al., "Synthesis and Biodistribution of .sup.18 F-Labeld Fluoronitroimidazoles: Potential In Vivo Markers of Hypoxic Tissue", Appl. Radiat. Isot. vol. 37, No. 7., pp. 599-605 (1986). |
Martin, G. V. et al., "Fluoromisonidazole A Metabolic Marker of Myocyote Hypoxia", Circulation Research, 67, pp. 240-244 (1990). |
Shelton, M.E. et al., "In Vivo Delineation of Myocardial Hypoxia During Coronary Occlusion Using Fluorin-18 Fluoromisonidazole and Positron Emission Tomography: A Potntial Approach for Idntification of Jeopardized Myocardium", J. Am. College Cardiology, vol. 16, No. 2, pp. 477-485 (Aug. 1990). |
Mannan, R.H. et al., "Radioiodinated 1-(5-Iodo-5-deoxy-.beta.-D-arabinofuranosyl)-2-nitroimidazole (Iodazomycin Arabinoside: IAZA): A Novel Marker of Tissue Hypoxia", The Journal of Nuclear Medicine, vol. 32, No. 9, pp. 1764-1770 (1991). |
Parker, D., "Harnessing the Kinetic Stability of Macrocyclic Complexes In Vivo, " presented at the 16th Int. Symp. on Macrocyclic Chemistry, Univ. of Sheffield, UK (Sep. 1-6, 1991). |
Yang Kixi, et al., "Synthesis of Metronidazole Derivative and Its Distribution in Sarcoma 180 Bearing Mice", J. of Medical Colleges of PLA; 2(3) pp. 265-269 (1987). |
Volkert, W.A. et al., ".sup.99m Tc-propylene amine oxime (99mTc-PnAO); a potential brain radiopharmaceutical", Eur. J. Nucl. Med., 9, pp. 511-516 (1984). |
Kung, H.F., et al., "Synthesis and Biodistribution of Neutral Lipid-Soluble Tc-99m Complexes that Cross the Blood-Brain Barrier", The Journal of Nuclear Medicine, 25, pp. 326-332 (1984). |
Lever, S.Z. et al., "Design, Preparation, and Biodistribution of a Technetium-99m Triaminedithiol Complex to Assess Regional Cerebral Blood Flow", J. Nucl. Med., 26, pp. 1287-1294 (1985). |
Jurisson et al., "Synthesis, Characterization, and X-ray Structural Determination of Technetium (V)-Oxo-Tetradentate Amine Oxime Complexes", Inorg. Chm., 25, pp. 543-549 (1986). |
Ding et al., "Review and Prospectives of Brain Radioppharmaceuticals", Nucl. Sci. J., 29(5), pp. 341-348 (1992). |
Fattorusso et al., J. Chem. Soc., Daltons Trans., p. 752 (1970). |
Moody et al., J. Chem. Soc. Perkin Trans. 1, (1), pp. 18-24 (1972). |
Svetkin et al., Zh. Obshch Khim, 41(11), pp. 2553-2555 (1971). |
Hook et al., Anti-Cancer Drug Res., 4(3), pp. 173-190 (1989). |
Curtius, Hechtenberg, J. Pract. Chem., 105, 314 (1922). |
Orna et al., "Correlation of Kinetic Parameters of Nitroreductase Enzymes with Redox Properties of Nitroaromatic Compounds", J. Biol. Chem., vol. 264, 21, pp. 12379-12384 (1989). |
Murmann, K., "The Interaction of 2-Methyl-2-amino-3-butanone Oxime with Nickel (II) and Copper (II) Ions", J. Am. Chem. Soc., pp. 4174-4180 (1958). |
Vassian et al., "Aromatization of an Aliphatic Amine Oxime Nickel (II) Complex by Molecular Oxygen", Inorg. Chemistry, vol. 6, No. 11, pp. 2043-2046 (1967). |
Murmann et al., "An Unsymmetrical transDinitrocobalt (III) Complex. A Crystal Structure Determination", Inorg. Chem., vol. 12, No. 11, pp. 2625-2631 (1973). |
Somin et al. "Oximes of w-dimethylaminoalkanals and their derivatives." Zh. Organ. Khim. vol.1 (11), pp. 1973-1976, (1965) (Russian) [Chem Abs.]vol. 64, p. 9582(f). |
Corbin, et al. "Substituted Cysteame Ligands and Their Complexes with Molybdenum(VI)", Inorg. Chem. vol. 23, pp. 3404-4312, (1984). |
Bryson, et al. "Neutral Technitium(V) Complexes with Amide-Thiol-Thioether Chelating Ligands" Inor. Chem. vol. 27, pp. 2154-2161, (1988). |
Panakaskie et al., Synthetic Communications, vol. 19, pp. 339-344 (1966). |
Biniakiewicz et al. "A New, General synthetic Route to Multidentate N,S Ligands for Use in Technetium-99m Radiopharmaceuticals." J. Med. Chem., vol. 35, pp. 274-279, (1992). |
Elliott et al., "Synthesis of Potential Antiradiation Agents from 3-substituted 2-oxazolidinones derived from Phenol, Benzenethiol and related compounds", J.Med. Chem., vol. 12, No. 2, pp. 253-257 (1969). |